IRIS Int (IRIS) Posts Q3 Loss of $0.06, Beats by 9c; Guides FY09
More News related to IRIS
- IRIS International to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009
- IRIS International's Sample Processing Division Enters Veterinary Ova and Parasite Detection Market With New Novel Sample Processing Kit
- IRIS International Names Lawrence J. Blecka, Ph.D., as Vice President, Research and Development of Iris Diagnostics Business Unit
- IRIS Int (IRIS) Posts Q3 Loss of $0.06, Beats by 9c; Guides FY09
- IRIS International (IRIS) Tops Q3 EPS by 1c; Maintains FY Guidance
More News related to Earnings
- Shields & Co. Downgrades ALLETE, Inc. (ALE) to Hold
- Scotia Capital Downgrades Grupo Aeroportuario del Centro (OMAB) to Sector Perform
- Goldman Sachs Upgrades Bradesco and Banco do Brasil; Downgrades Bancolombia
- Wedbush Downgrades Burger King (BKC) to Underperform
- Morgan Stanley Upgrades Safeway (SWY), Downgrades SUPERVALU (SVU)
IRIS International Inc. (NASDAQ: IRIS) reports Q3 loss of $0.06, 9 cents better than the analyst estimate of $0.15. Revenue for the quarter was $22.19 million, which compares to the estimate of $27.53 million.
Maintains FY09 estimates. Sees revs of $94 - $96 million, and EPS of $0.40 - $0.42.
Related Categories
EarningsGuidance
Stocks Mentioned
-0.06Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
